Methotrexate Clinical Trials

6 recruitingLast updated: June 18, 2026

There are 6 actively recruiting methotrexate clinical trials across 9 countries. Studies span Not Applicable, Phase 3, Phase 2, Phase 4. Top locations include Strasbourg, France, Angers, France, Barcelona, Spain. Updated daily from ClinicalTrials.gov.


Methotrexate Trials at a Glance

6 actively recruiting trials for methotrexate are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Strasbourg, Angers, and Barcelona. Lead sponsors running methotrexate studies include Ain Shams University, AstraZeneca, and Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.

Browse methotrexate trials by phase

Treatments under study

About Methotrexate Clinical Trials

Looking for clinical trials for Methotrexate? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Methotrexate trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Methotrexate clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Phase 3

Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)

Urinary Bladder NeoplasmsImmune Checkpoint InhibitorsMethotrexate+4 more
AstraZeneca150 enrolled59 locationsNCT06960577
Recruiting
Phase 2

Role of Methotrexate in Ultrasound Proven Synovitis in Primary Knee OA

MethotrexateOsteo Arthritis of the KneeSynovitis of Knee
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh70 enrolled1 locationNCT07161336
Recruiting
Not Applicable

Efficacy and Safety of Resveratrol in Patients With Rheumatoid Arthritis.

Rheumatic ArthritisMethotrexateC-Reactive Protein+6 more
Ain Shams University118 enrolled1 locationNCT07089381
Recruiting
Phase 3

Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial

Crohn DiseaseMethotrexateAzathioprine
Centre Hospitalier Universitaire, Amiens166 enrolled1 locationNCT05040464
Recruiting
Phase 4

Clinical Trial Evaluating Methotrexate or Leflunomide + Targeted Therapy Versus Methotrexate or Leflunomide + Sulfasalazine + Hydroxychloroquine in Patients With Rheumatoid Arthritis and Insufficient Response to Methotrexate or Leflunomide

Rheumatoid ArthritisInsufficient Response to Methotrexate or Leflunomide
University Hospital, Strasbourg, France286 enrolled1 locationNCT02714634
Recruiting
Not Applicable

Local vs Systemic Methotrexate in Management of Uterine Ectopic Pregnancy

MethotrexateLocalSystemic+1 more
Tanta University34 enrolled1 locationNCT06554470